These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 12943643

  • 1. Solitary pulmonary nodules: impact of quantitative contrast-enhanced CT on the cost-effectiveness of FDG-PET.
    Comber LA, Keith CJ, Griffiths M, Miles KA.
    Clin Radiol; 2003 Sep; 58(9):706-11. PubMed ID: 12943643
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules.
    Gould MK, Sanders GD, Barnett PG, Rydzak CE, Maclean CC, McClellan MB, Owens DK.
    Ann Intern Med; 2003 May 06; 138(9):724-35. PubMed ID: 12729427
    [Abstract] [Full Text] [Related]

  • 3. Solitary pulmonary nodules: accuracy and cost-effectiveness of sodium iodide FDG-PET using Australian data.
    Keith CJ, Miles KA, Griffiths MR, Wong D, Pitman AG, Hicks RJ.
    Eur J Nucl Med Mol Imaging; 2002 Aug 06; 29(8):1016-23. PubMed ID: 12173015
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany.
    Dietlein M, Weber K, Gandjour A, Moka D, Theissen P, Lauterbach KW, Schicha H.
    Eur J Nucl Med; 2000 Oct 06; 27(10):1441-56. PubMed ID: 11083532
    [Abstract] [Full Text] [Related]

  • 5. Analysis models to assess cost effectiveness of the four strategies for the work-up of solitary pulmonary nodules.
    Tsushima Y, Endo K.
    Med Sci Monit; 2004 May 06; 10(5):MT65-72. PubMed ID: 15114278
    [Abstract] [Full Text] [Related]

  • 6. Comparative accuracy and cost-effectiveness of dynamic contrast-enhanced CT and positron emission tomography in the characterisation of solitary pulmonary nodules.
    Gilbert FJ, Harris S, Miles KA, Weir-McCall JR, Qureshi NR, Rintoul RC, Dizdarevic S, Pike L, Sinclair D, Shah A, Eaton R, Jones J, Clegg A, Benedetto V, Hill J, Cook A, Tzelis D, Vale L, Brindle L, Madden J, Cozens K, Little L, Eichhorst K, Moate P, McClement C, Peebles C, Banerjee A, Han S, Poon FW, Groves AM, Kurban L, Frew A, Callister MEJ, Crosbie PA, Gleeson FV, Karunasaagarar K, Kankam O, George S.
    Thorax; 2022 Oct 06; 77(10):988-996. PubMed ID: 34887348
    [Abstract] [Full Text] [Related]

  • 7. Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT.
    Orlacchio A, Schillaci O, Antonelli L, D'Urso S, Sergiacomi G, Nicolì P, Simonetti G.
    Radiol Med; 2007 Mar 06; 112(2):157-73. PubMed ID: 17361379
    [Abstract] [Full Text] [Related]

  • 8. The solitary pulmonary nodule: aggressive excisional strategy.
    Decamp MM.
    Semin Thorac Cardiovasc Surg; 2002 Jul 06; 14(3):292-6. PubMed ID: 12232872
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
    Christensen JA, Nathan MA, Mullan BP, Hartman TE, Swensen SJ, Lowe VJ.
    AJR Am J Roentgenol; 2006 Nov 06; 187(5):1361-7. PubMed ID: 17056930
    [Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach.
    Vriens D, Adang EM, Netea-Maier RT, Smit JW, de Wilt JH, Oyen WJ, de Geus-Oei LF.
    J Clin Endocrinol Metab; 2014 Sep 06; 99(9):3263-74. PubMed ID: 24873995
    [Abstract] [Full Text] [Related]

  • 11. [Whether and under what conditions FDG-PET might be cost-effective in evaluating solitary pulmonary nodules depicted on lung cancer screening in Japan].
    Tsushima Y, Aoki J, Endo K.
    Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Sep 06; 63(8):390-8. PubMed ID: 14587408
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of initial diagnostic strategies for pulmonary nodules presenting to thoracic surgeons.
    Deppen SA, Davis WT, Green EA, Rickman O, Aldrich MC, Fletcher S, Putnam JB, Grogan EL.
    Ann Thorac Surg; 2014 Oct 06; 98(4):1214-22. PubMed ID: 25087933
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic Accuracy of a Convolutional Neural Network Assessment of Solitary Pulmonary Nodules Compared With PET With CT Imaging and Dynamic Contrast-Enhanced CT Imaging Using Unenhanced and Contrast-Enhanced CT Imaging.
    Weir-McCall JR, Debruyn E, Harris S, Qureshi NR, Rintoul RC, Gleeson FV, Gilbert FJ, SPUtNIk Investigators.
    Chest; 2023 Feb 06; 163(2):444-454. PubMed ID: 36087795
    [Abstract] [Full Text] [Related]

  • 15. Solitary pulmonary nodule: Comparison of quantitative capability for differentiation and management among dynamic CE-perfusion MRI at 3 T system, dynamic CE-perfusion ADCT and FDG-PET/CT.
    Ohno Y, Fujisawa Y, Yui M, Takenaka D, Koyama H, Sugihara N, Yoshikawa T.
    Eur J Radiol; 2019 Jun 06; 115():22-30. PubMed ID: 31084755
    [Abstract] [Full Text] [Related]

  • 16. The role of ¹⁸F-FDG PET or ¹⁸F-FDG-PET/CT in the evaluation of solitary pulmonary nodules.
    Li W, Pang H, Liu Q, Zhou J.
    Eur J Radiol; 2015 Oct 06; 84(10):2032-7. PubMed ID: 26094866
    [Abstract] [Full Text] [Related]

  • 17. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography.
    Degirmenci B, Wilson D, Laymon CM, Becker C, Mason NS, Bencherif B, Agarwal A, Luketich J, Landreneau R, Avril N.
    Nucl Med Commun; 2008 Jul 06; 29(7):614-22. PubMed ID: 18528183
    [Abstract] [Full Text] [Related]

  • 18. Decision-tree sensitivity analysis for cost-effectiveness of chest 2-fluoro-2-D-[(18)F]fluorodeoxyglucose positron emission tomography in patients with pulmonary nodules (non-small cell lung carcinoma) in Japan.
    Kosuda S, Ichihara K, Watanabe M, Kobayashi H, Kusano S.
    Chest; 2000 Feb 06; 117(2):346-53. PubMed ID: 10669673
    [Abstract] [Full Text] [Related]

  • 19. Solitary pulmonary nodules: Comparison of dynamic first-pass contrast-enhanced perfusion area-detector CT, dynamic first-pass contrast-enhanced MR imaging, and FDG PET/CT.
    Ohno Y, Nishio M, Koyama H, Seki S, Tsubakimoto M, Fujisawa Y, Yoshikawa T, Matsumoto S, Sugimura K.
    Radiology; 2015 Feb 06; 274(2):563-75. PubMed ID: 25203128
    [Abstract] [Full Text] [Related]

  • 20. Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography.
    Klose T, Leidl R, Buchmann I, Brambs HJ, Reske SN.
    Eur J Nucl Med; 2000 Oct 06; 27(10):1457-64. PubMed ID: 11083533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.